OneMedNet Corporation
ONMDW
NASDAQ Global Market0.03
USD
+0.00
- -
CIK
0001849380
ISIN
US68270C1119
CUSIP
68270C111
Return %
Stock
S&P500
1Y
-19.43
18.21
3Y
37.61
64.38
5Y
37.61
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Aaron Green
- Full Time Employees
- 23
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 6385 Old Shady Oak Road Eden Prairie MN United States of America 55344
- IPO Date
- Aug 25, 2022
- CIK
- 0001849380
- Website
- onemednet.com
- Similar Companies
- Business
- OneMedNet Corporation specializes in providing regulatory-grade, real-world data solutions primarily for the healthcare, life sciences, and clinical research sectors. The company offers a proprietary iRWD™ platform that delivers comprehensive, de-identified clinical data including medical imaging, electronic health records, and associated patient contextual records. Its core products include secure, AI-powered real-world data streams that support drug development, medical device innovation, and healthcare AI applications across a network of over 2,130 healthcare provider sites globally. OneMedNet's services enable clients to access live clinical exams, images, and de-identified patient records stripped of PII and HIPAA-sensitive details, ensuring regulatory compliance and robust data privacy. The company integrates advanced AI algorithms for automated and human-in-the-loop data curation, enhancing data quality, scalability, and actionable insights tailored for healthcare, finance, and retail industries. Founded in 2009 and headquartered in the United States, OneMedNet operates a widely federated network facilitating access to over 47 million unique de-identified patient records and more than 186 million clinical exams and images as of late 2025. The firm targets pharmaceutical companies, healthcare providers, researchers, and AI developers as clients, emphasizing real-world evidence and data-driven research to accelerate clinical trial design and outcomes. Recent major developments include a strategic multi-year partnership with Palantir Technologies, integrating Palantir's AI platform to enhance OneMedNet's analytics capability and providing faster data discovery, improved AI-driven de-identification, and federated multimodal data integration. This alliance supports a scalable subscription revenue model and a pilot integration showcased at leading industry conferences such as RSNA 2025 and ISPOR Europe. OneMedNet also completed a significant network expansion by adding approximately 380 provider sites since mid-2025, increasing patient records by 38% and clinical imaging studies by 37%. Financially, the company reported an 815% year-over-year increase in Q3 2025 bookings to $1.1 million, reflecting robust market demand and operational growth, supported by strategic capital infusions and debt reductions within the past year. OneMedNet completed a business combination with Data Knights Acquisition Corp in 2024 to become publicly traded under ticker ONMDW. The company continues to execute its growth strategy by expanding partnerships, enhancing its AI-ready data platform, and scaling its live real-world data network to serve evolving clinical and research needs globally.
OneMedNet Co. (NASDAQ:ONMDW) Sees Large Increase in Short Interest